Acurx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.151; its P/E ratio is -1.77; Acurx Pharmaceuticals is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -5.11M	$ -3.11M	$ -3.45M	$ -2.90M	$ -3.26M
EBITDA	$ -5.11M	$ -3.11M	-	$ -2.90M	$ -3.26M
Net Income Common Stockholders	$ -5.11M	$ -3.12M	$ -3.45M	$ -2.90M	$ -3.26M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.50M	$ 7.10M	$ 9.10M	$ 7.20M	$ 9.11M
Total Assets	$ 7.71M	$ 7.21M	$ 9.19M	$ 7.41M	$ 9.38M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -7.50M	$ -7.10M	$ -9.10M	$ -7.20M	$ -9.11M
Total Liabilities	$ 3.04M	$ 3.22M	$ 3.02M	$ 2.07M	$ 2.06M
Stockholders Equity	$ 4.67M	$ 3.93M	$ 6.22M	$ 5.31M	$ 7.32M
Cash Flow	-
Free Cash Flow	$ -4.20M	$ -2.09M	-	$ -1.93M	$ -1.50M
Operating Cash Flow	$ -4.20M	$ -2.09M	$ -1.58M	$ -1.93M	$ -1.50M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 4.62M	-	$ 3.54M	-	$ -1.00

Currency in USD

Acurx Pharmaceuticals Earnings and Revenue History

Income Statement >

Acurx Pharmaceuticals Debt to Assets

Balance Sheet >

Acurx Pharmaceuticals Cash Flow

Cash Flow >

Acurx Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing